Few industries have been kicking tail and taking names more so than marijuana. Having long been considered an illicit substance that was cast aside by legislators around the globe, cannabis is now a legitimate business model. Globally, over 40 countries have given medical marijuana the green light, with two (Canada and Uruguay) also allowing the recreational sale of the drug.
It's also a business model that's generating big-time returns for investors who've had the wherewithal to bet on marijuana stocks from an early date and hang on for the ride. Sure, the better than 50% gain in the Horizons Marijuana Life Sciences ETF since the beginning of the year might appear impressive, but it's peanuts compared to the triple-digit or quadruple-digit percentage gains that some of the biggest pot stocks have delivered since the beginning of 2016, which is when marijuana mania really kicked into high gear.
Today, no marijuana stocks that garner more attention from Wall Street or investors than Aurora Cannabis (NYSE:ACB), Canopy Growth (NYSE:CGC), and Cronos Group (NASDAQ:CRON). This trio is also responsible for some of the most robust returns since the start of 2016. Here you'll find out how much money you'd have today if you had invested a cool $1,000 into each of these marijuana stocks in 2016.